Nutrition for Chronic Daily Headache
關鍵詞
抽象
描述
CDH is characterized by structural and functional immune and nervous system derangements. Specifically, disturbed regulation of the following critically important biochemical processes has been demonstrated: 1) inflammation; 2) neuronal membrane excitability; and 3) monoamine neurotransmitter signaling. Accordingly, major classes of medications used for chronic pain (anti-inflammatories, anticonvulsants, and antidepressants) target these processes.
Foods consist of combinations of nutrient molecules that are incorporated into human tissues, and enter into and regulate highly leveraged human biochemical pathways. By altering the structure and function of the nervous system and immune system, and regulating biochemical processes believed to play causal roles in the development and maintenance of chronic pain, dietary choices may play a critical role in the initiation and/or perpetuation of CDH.
Multifaceted, targeted dietary manipulation, directed towards correcting underlying biochemical derangements, represents a novel therapeutic approach to the management of chronic pain. Improved understanding of the relationships between dietary selections and chronic pain promises to benefit the estimated 10 million Americans with CDH and possibly an even larger population with chronic pain from any origin. For a more detailed description, please refer to the complete rationale and literature review accompanying grant application.
Major research questions for this proposal include:
A. Is it possible to implement a controlled dietary trial comparing two analgesic dietary interventions for subject with CDH? and B. What are the preliminary estimates of impact of targeted analgesic dietary interventions on headache frequency compared with one another and the baseline headache frequency in patients for CDH? C. What is the rate and extent of change in %n6 in HUFA with two targeted interventions? There is also an exploratory portion of the study to gather more information about the potential relationship between nutrient and pain to inform intended future trials. The study is needed to assess the potential utility of a dietary approach for chronic pain, which may have major public health implications.
日期
| 最後驗證: | 10/31/2012 |
| 首次提交: | 05/27/2010 |
| 提交的預估入學人數: | 07/01/2010 |
| 首次發布: | 07/04/2010 |
| 上次提交的更新: | 02/16/2017 |
| 最近更新發布: | 02/22/2017 |
| 實際學習開始日期: | 06/30/2009 |
| 預計主要完成日期: | 10/31/2011 |
| 預計完成日期: | 11/30/2011 |
狀況或疾病
干預/治療
Other: Diet A
Other: Diet B
相
手臂組
| 臂 | 干預/治療 |
|---|---|
| Experimental: Diet A This diet is high in omega-3 fatty acids, low in trans fatty acids, and low in omega-6 fatty acids. Subjects are encouraged to eat fatty fish daily (e.g., salmon), to limit vegetable oil intake, and to eat fruits, vegetables and whole grains. Specifically formulated and other provided foods for this group will include salmon-salad sandwiches, hummus with olive oil, other bean dips and bean dishes, frozen and canned fish, and blueberry-flax muffins. | Other: Diet A Subjects receive dietary counseling, food for two meals and two snacks daily, and access to a website with recipes, approved food lists, and dining out guides for a 12-week intervention. |
| Experimental: Diet B This diet is low in trans fatty acids and low in omega-6 fatty acids. Subjects are encouraged to to limit vegetable oil intake, to replace meats and eggs with beans and lean fish/shellfish, and to eat fruits, vegetables and whole grains. Specifically formulated and other provided foods for this group will include hummus with olive oil, other bean dips and bean dishes, lean fish and shellfish,and blueberry muffins. | Other: Diet B Over a 12-week intervention, subjects receive dietary counseling, food for two meals and two snacks daily, and access to a website with recipes, approved food lists, and dining out guides. |
資格標準
| 有資格學習的年齡 | 18 Years 至 18 Years |
| 有資格學習的性別 | All |
| 接受健康志願者 | 是 |
| 標準 | Inclusion Criteria: - 18 years of age and older - either gender - meeting the 2004 International Classification of Headache Disorders (ICHD - II) criteria for the following forms of CDH (15 or more headache days per month and a headache history of more than two years with chronic migraine, transformed episodic migraine into CDH, chronic tension-type headache and new persistent daily headache) - under the care of a neurologist - willing and able to document headache characteristics and use of medications, as well as complete the assessment instruments - able to come in for 3 dietitian-administered dietary counseling sessions over 12 weeks - able to speak and understand English Exclusion Criteria: - analgesic rebound headache - hemicrania continua - drug-induced headache - post-traumatic headache - significant, symptomatic uncontrolled psychosis - undergoing current treatment for a major medical illness such as malignancy, autoimmune or immune deficiency disorder - pregnancy - clotting disorders - history of cranial or neck surgery within two years - vasculitis - chronic subdural hematoma - history of meningitis - history of subarachnoid or intracerebral hemorrhage - history of eating disorder - regular use of supplemental omega-3 fatty acids or gamma-linolenic acid |
結果
主要結果指標
1. Headache Impact Test [Pre-intervention and post-intervention]
次要成果指標
1. Omega-3 and omega-6 fatty acids in RBCs and plasma [pre-intervention and at 4 and 8 weeks, and at the conclusion of the intervention.]
